U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. Congressional Testimony
  1. News & Events

Congressional Testimony

This section includes testimony by FDA officials before House and Senate Committees and Subcommittees. For testimony from previous years, see the FDA Archive.

Office of Legislation




Date Testimony Speaker Excerpt
Preparing for the Next Pandemic: Lessons Learned and the Path Forward - 11/14/2024 Hilary Marston
Evaluating FDA Human Foods and Tobacco Programs - 09/10/2024 Jim Jones, Brian King
Combatting The Youth Vaping Epidemic By Enhancing Enforcement Against Illegal E-Cigarettes - 06/12/2024 Brian King
Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices - 05/22/2024 Patrizia Cavazzoni,, Peter Marks
Oversight of the U.S. Food and Drug Administration - 04/11/2024 Robert Califf
Assessing America's Vaccine Safety Systems, Part 1 - 02/15/2024 Peter Marks
FDA Oversight Part II: Responsibility for the Infant Formula Shortage - 05/11/2023
Preparing for and Responding to Future Public Health Risks - 05/11/2023 Robert Califf
Preparing for the Next Public Health Emergency: Reauthorizing the Pandemic and All-Hazards Preparedness Act - 05/04/2023 Robert Califf
Reauthorization of the Animal Drug User Fee Programs - 03/30/2023 Tracey Forfa
Download XLSX
Back to Top